This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Whitepapers

Drug Serialization — Local Knowledge The Key To Protecting Patients In U.S. And International Markets

Evolving track-and-trace rules in key markets are driving pharmaceutical industry demand for adaptable contractors with regional expertise, according to Ian Parsonage, Senior Director, Global Serialization Services at PCI Pharma Services.

Beginning in late November 2017, pharmaceuticals sold in the U.S. must be marked with a National Drug Code (NDC), a serial number, a lot number, and an expiration date. The requirement, stipulated in 2013’s Drug Quality and Security Act (DQSA) (H.R. 3204), is designed to harmonize existing state-to-state variations in track-and-trace laws.

Drug Serialization

December 20, 2016

Webflow Mobile App Launch

PCI Is pleased to announce the launch of a mobile application to provide more convenient access to its client services... View Article

PCI Announces Further Investment in Fully Contained Xcelodose® 600S Technology Delivering Excellence in Clinical Services

PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at our center... View Article